We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPKI
1401
NPK International
NPKI
$1.19B
-25,400
Closed -$195K
SGI
1402
Somnigroup International
SGI
$13.6B
-7,187
Closed -$407K
JOYY
1403
JOYY Inc
JOYY
$3.78B
-8,262
Closed -$346K
LGF.B
1404
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-22,752
Closed -$172K
BECN
1405
DELISTED
Beacon Roofing Supply, Inc.
BECN
-2,885
Closed -$293K
LGTY
1406
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-17,238
Closed -$191K
NVRO
1407
DELISTED
NEVRO CORP.
NVRO
-20,916
Closed -$77.8K
NARI
1408
DELISTED
Inari Medical, Inc. Common Stock
NARI
-21,895
Closed -$1.12M
SWI
1409
DELISTED
SolarWinds Corporation Common Stock
SWI
-73,592
Closed -$1.05M

Similar funds

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.